# ImmuneBridge

**Canonical:** https://apis.io/providers/immunebridge/  
**Website:** https://www.immunebridge.com/  
**APIs profiled:** 0

ImmuneBridge is a San Francisco biotech company building a first-in-class integrated screening and manufacturing platform for allogeneic cell therapies. The company screens and expands stem cells from multiple sources (umbilical cord blood, mobilized blood, bone marrow), uses high-throughput automated assays with machine-learning models to predict donor and process performance early, and scales production with IBR403, a small molecule enabling up to 100,000-fold expansion of hematopoietic stem cells. The stated goal is to manufacture tens of thousands of affordable, high-quality immune cell doses (HSCs, NK cells, T cells, and more) from a single cord blood unit. ImmuneBridge is backed by Insight Partners, NFX Bio, M Ventures, and other institutional investors. This profile was enriched by the API Evangelist pipeline; the company publishes no public API or developer surface.

## Kin Score — 6.7 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 6.7).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 10.5 |
| Access Clarity | 10.5 |

Regulatory layer — **Health**: 12.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Immunebridge Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotech, Cell Therapy, Therapeutics, Immunology, Bioprocessing, Life Sciences

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/immunebridge/). Scores are computed from the provider's own public artifacts under a published rubric.